Data Platform
Sign InStart a Free Trial

HCPCS J9394 Fee Schedule

Last Verified: August 2025

Healthcare providers use this code to document and receive reimbursement for visits that address moderate-level medical decision-making, often including multiple diagnoses or prescription management.

Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
Key FactDetail
Service Type

Chemotherapy Drugs

Common Place of Service

None

11 - Office

22 - On Campus-Outpatient Hospital

Common Modifiers
Complexity LevelModerate

National average reimbursement for HCPCS J9394 by major payers:

bcbs

$42.79

uhc

$56.57

aetna

$56.25

cigna

$55.83

Preview provider-level rates for...
For billing codeHCPCS J9394
PayerCodeRateNPITax IDStateSpecialty

Select a payer to view fee schedule data

Choose a payer from the options above to see rates for HCPCS J9394

Want to see your competitors' rates?

Start your trial today to unlock complete access to provider rates and fee schedules in your area.

Here's what you can do with PayerPrice

Renegotiate your managed care contracts

Benchmark your current rates against market averages to identify opportunities for rate optimization.

Prospect for new business using fee schedules

Access every provider's negotiated rates for every billing code in your market to inform your prospecting strategies.

Integrate real-time payer data into your workflows

Automatically keep fee schedules up-to-date without adding yet another log-in to your insurance systems. Connect via API or SQL.

PayerPrice shows you the exact negotiated rates that insurers publish under federal transparency rules.
We display the raw data directly from insurers' files, giving you the same information they make public. Learn more about Price Transparency.

HCPCS J9394 vs. Other Chemotherapy Drugs Codes

The HCPCS J9394 code is part of the Chemotherapy Drugs services . It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.

The HCPCS J9394 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.

CodeComplexityDescription
J9393Low
Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg
J9394Low
Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
J9395Low
Injection, fulvestrant, 25 mg

What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J9394. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the J9394 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts


Private Insurance Rates

Negotiated rates between providers and insurance companies


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.

COMPLEMENTARY MARKET OVERVIEW

Let's review your payer contracts side-by-side with the market.

Bring your top codes (like HCPCS J9394) and we'll show you how you compare in 15 minutes or less.